Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples